GlycoMimetics Inc (GLYC) Actualités

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid...

Form SC 13D - General Statement of Acquisition of Beneficial Ownership